Endometrial Cancer

被引：487

作者：

Lu, Karen H. ^{[1
]}

Broaddus, Russell R. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, 1515 Holcombe Blvd,Unit 1362, Houston, TX 77030 USA

[2] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 21期

关键词：

MIXED MULLERIAN TUMORS; FEMALE GENITAL-TRACT; SEROUS-CARCINOMA UPSC; BODY-MASS INDEX; PHASE-II TRIAL; RACIAL DISPARITIES; LYNCH-SYNDROME; BREAST-CANCER; RISK-FACTORS; CARBOPLATIN-PACLITAXEL;

D O I：

10.1056/NEJMra1514010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Endometrial carcinoma is diagnosed in about 58,500 women in the United States per year. It is linked with obesity, excess estrogen, and the Lynch syndrome. Oral contraceptives lower the risk by 30 to 40%. Most patients undergo surgery with or without radiation therapy.

引用

页码：2053 / 2064

页数：12

共 89 条

[1]

Abeln ECA, 1997, J PATHOL, V183, P424

[2] A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer [J].

Aghajanian, Carol ;

Filiaci, Virginia ;

Dizon, Don S. ;

Carlson, Jay W. ;

Powell, Matthew A. ;

Secord, Angeles Alvarez ;

Tewari, Krishnansu S. ;

Bender, David P. ;

O'Malley, David M. ;

Stuckey, Ashley ;

Gao, Jianjiong ;

Dao, Fanny ;

Soslow, Robert A. ;

Lankes, Heather A. ;

Moore, Kathleen ;

Levine, Douglas A. .

GYNECOLOGIC ONCOLOGY, 2018, 150 (02) :274-281

[3] Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies [J].

Allen, N. ;

Peto, R. ;

Beral, V. ;

Kan, S. W. ;

Reeves, G. ;

Sweetland, S. ;

Stevens, R. ;

Yang, T. O. .

LANCET ONCOLOGY, 2015, 16 (09) :1061-1070

[4]

[Anonymous], 2003, WHO CLASSIFICATION T

[5]

[Anonymous], 2014, OBSTET GYNECOL

[6] Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis [J].

Barry, John A. ;

Azizia, Mallika M. ;

Hardiman, Paul J. .

HUMAN REPRODUCTION UPDATE, 2014, 20 (05) :748-758

[7] Tamoxifen therapy for breast cancer and endometrial cancer risk [J].

Bernstein, L ;

Deapen, D ;

Cerhan, JR ;

Schwartz, SM ;

Liff, J ;

McGann-Maloney, E ;

Perlman, JA ;

Ford, L .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (19) :1654-1662

[8] Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults [J].

Bhaskaran, Krishnan ;

Douglas, Ian ;

Forbes, Harriet ;

dos-Santos-Silva, Isabel ;

Leon, David A. ;

Smeeth, Liam .

LANCET, 2014, 384 (9945) :755-765

[9]

Bregar AJ, 2017, GYNECOL ONCOL, V145, P114, DOI [10.1016/j.ygyno.2017.01.024, 10.1016/j.ygyno.20]

[10] REPRODUCTIVE, MENSTRUAL, AND MEDICAL RISK-FACTORS FOR ENDOMETRIAL CANCER - RESULTS FROM A CASE-CONTROL STUDY [J].

BRINTON, LA ;

BERMAN, ML ;

MORTEL, R ;

TWIGGS, LB ;

BARRETT, RJ ;

WILBANKS, GD ;

LANNOM, L ;

HOOVER, RN .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (05) :1317-1325

← 1 2 3 4 5 6 7 8 9 →